Literature DB >> 3320618

Clindamycin.

A S Klainer1.   

Abstract

Clindamycin is an excellent, well tolerated, effective antimicrobial agent that can be used clinically in the treatment of specific anaerobic infections as well as clinical situations when both S. aureus and anaerobes occur together.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3320618     DOI： 10.1016/s0025-7125(16)30804-5

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN： 0025-7125            Impact factor:   5.456


  7 in total

Review 1.  Antianaerobic antimicrobials: spectrum and susceptibility testing.

Authors:  Itzhak Brook; Hannah M Wexler; Ellie J C Goldstein
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

2.  Current indications for the use of clindamycin: A critical review.

Authors:  M Smieja
Journal:  Can J Infect Dis       Date:  1998-01

3.  Quantitative study of antibiotic-induced susceptibility to Clostridium difficile enterocecitis in hamsters.

Authors:  H E Larson; S P Borriello
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

4.  In vitro and in vivo synergy of fosmidomycin, a novel antimalarial drug, with clindamycin.

Authors:  Jochen Wiesner; Dajana Henschker; David B Hutchinson; Ewald Beck; Hassan Jomaa
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

5.  Investigation and management of Clostridium difficile colonisation in a paediatric oncology unit.

Authors:  I Schuller; V Saha; L Lin; J Kingston; T Eden; S Tabaqchali
Journal:  Arch Dis Child       Date:  1995-03       Impact factor: 3.791

6.  Oral clindamycin causing acute cholestatic hepatitis without ductopenia: a brief review of idiosyncratic drug-induced liver injury and a case report.

Authors:  Harsha Moole; Zohair Ahmed; Nibha Saxena; Srinivas R Puli; Sonu Dhillon
Journal:  J Community Hosp Intern Med Perspect       Date:  2015-10-19

7.  Epidemiological Characteristics and Drug Resistance Analysis of Cerebrospinal Fluid Microbial Infections in Wenzhou Area.

Authors:  Teng Zhou; Mengjiao Kuang; Shirui Huang; Jizhen Li; Qipeng Xie
Journal:  Infect Drug Resist       Date:  2021-06-03       Impact factor: 4.003
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.